LONDON, May 13 - Genomic companies could be forgiven for asking whether patenting really is the best way to protect their IP. The costs of obtaining a biotech patent are large, the prosecution period is often lengthy--not to say uncertain-and, following grant, the lifetime of a patent may only be a decade or so.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.